Trial Profile
Effects of three oral dosages of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-day, single-blind, international multicentre study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Aladorian (Primary)
- Indications Polymorphic catecholergic ventricular tachycardia
- Focus Therapeutic Use
- 06 Oct 2021 Trial has been completed in France (global end of the trial 2011-01-21) as per European Clinical Trials Database record.
- 14 Jun 2011 New trial record